Background The gastrointestinal peptide hormone ghrelin was discovered in 1999 as the
endogenous ligand of the growth hormone secretagogue receptor. Increasing evidence …

Anorexia nervosa is prevalent in adolescents and young adults, and endocrine changes
include hypothalamic amenorrhoea; a nutritionally acquired growth-hormone resistance …

Ghrelin, an acylated peptide hormone of 28 amino acids, is an endogenous ligand of the
released growth hormone secretagogue receptor (GHSR). Ghrelin has been isolated from …

Over the past decade, considerable advances have been made in understanding genetic
influences on eating pathology. Eating disorders aggregate in families, and twin studies …

Ghrelin was discovered in 1999 as the endogenous ligand of the growth-hormone
secretagogue receptor 1a (GHSR1a). Since then, ghrelin has been found to exert a plethora …

Anorexia nervosa (AN) is classically defined as a condition in which an abnormally low body
weight is associated with an intense fear of gaining weight and distorted cognitions …

Cachexia is a multifactorial syndrome defined by significant body weight loss, fat and muscle
mass reduction, and increased protein catabolism. Protein energy wasting (PEW) is …

Ghrelin, a 28-amino acid peptide hormone expressed in X/A-like endocrine cells of the
stomach, is the only known peripherally produced and centrally acting peptide that …

Background Eating disorders (ED) such as anorexia nervosa (AN), bulimia nervosa (BN),
and binge eating disorder (BED) are often accompanied by a variety of psychological and …

Ghrelin is a 28-amino-acid peptide hormone, first described in 1999 and broadly expressed
in the organism. As the only known orexigenic hormone secreted in the periphery, it …